COMBINED AND SEQUENTIAL TREATMENT USING FCE-21336, A NEW PROLACTIN-LOWERING DRUG, AND MEDROXYPROGESTERONE ACETATE (MPA) IN DMBA-INDUCED TUMORS IN RATS

被引:5
作者
ZACCHEO, T
CASAZZA, AM
DISALLE, E
POLLINI, C
DIMARCO, A
机构
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1984年 / 20卷 / 09期
关键词
D O I
10.1016/0277-5379(84)90129-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1193 / 1197
页数:5
相关论文
共 22 条
[1]  
BAKER RJ, 1978, GLIM SYSTEM RELEASE, V3
[2]  
BALDRATTI G, 1960, ANN OSTET GINECOL ME, V32, P594
[3]  
Cox D. R., 1989, BIOMETRICS, V32, DOI DOI 10.2307/2531476
[4]  
DANGUY A, 1980, PROGR CANC RES THERA, V15, P21
[5]  
DISALLE E, 1982, J ENDOCRINOL INVE S1, V5, P45
[6]  
DISALLE E, 1983, J ENDOCRINOL INVE S1, V6, P6
[7]  
DOGLIOTTI L, 1979, CANCER TREAT REP, V63, P1219
[8]   CORRELATION BETWEEN INHIBITORY EFFECT ON PROLACTIN SECRETION AND ANTI-TUMOR ACTIVITY OF NEW ERGOLINE COMPOUNDS ON DMBA-INDUCED TUMORS IN RATS [J].
FORMELLI, F ;
ZACCHEO, T ;
DISALLE, E ;
ORNATI, G ;
DIMARCO, A .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (11) :1545-1551
[9]  
FORMELLI F, 1979, CHEMIOTER ONCOL, V4, P282
[10]  
GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1